Stephen Hahn, FDA commissioner (Alex Brandon/AP Images)
August 31, 2020 06:38 AM EDTUpdated 09:54 AM
Coronavirus

Covid-19 roundup: Most Amer­i­cans wor­ry pol­i­tics is put be­fore sci­ence amid vac­cine rush; Dai­ichi Sankyo fur­thers mR­NA shot R&D

John Carroll

Editor & Founder

Max Gelman

Senior Editor

Amber Tong

The re­cent turn of events be­tween the White House and the FDA is cast­ing se­ri­ous doubts on the Covid-19 vac­cine ap­proval process among Amer­i­cans, a …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Pfiz­er look­ing to sell hos­pi­tal drugs unit — re­ports

As­traZeneca CEO reaf­firms com­mit­ment to Chi­na fol­low­ing ex­ec­u­tive's de­ten­tion

'Ex­per­tise is a re­al thing': FDA com­mis­sion­er warns of po­lit­i­cal risk to agency

Mer­ck, As­traZeneca tout Phase 3 win for can­cer-turned-rare dis­ease drug

No­var­tis pays $150M up­front to Schrödinger in new drug deal, ramps up soft­ware use

sponsored

What Will It Take to Re­verse Fi­bro­sis in Pa­tients with Ad­vanced MASH?

A service from the Financial Times